Efficacy Study in Lumbosacral Radiculopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 7, 2010

Primary Completion Date

August 23, 2010

Study Completion Date

August 23, 2010

Conditions
Pain, Neuropathic
Interventions
DRUG

Placebo

Placebo to match GW856553

DRUG

GS856553

GW586553 7.5mg bid

Trial Locations (17)

2317

GSK Investigational Site, Hamar

2970

GSK Investigational Site, Hoersholm

5000

GSK Investigational Site, Odense C

7030

GSK Investigational Site, Trondheim

20255

GSK Investigational Site, Hamburg

22767

GSK Investigational Site, Hamburg

69250

GSK Investigational Site, Schönau

69394

GSK Investigational Site, Lyon

75181

GSK Investigational Site, Paris

76230

GSK Investigational Site, Bois-Guillaume

80333

GSK Investigational Site, Munich

92100

GSK Investigational Site, Boulogne-Billancourt

06002

GSK Investigational Site, Nice

04109

GSK Investigational Site, Leipzg

0027

GSK Investigational Site, Oslo

SE-703 62

GSK Investigational Site, Örebro

SE-115 22

GSK Investigational Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01110057 - Efficacy Study in Lumbosacral Radiculopathy | Biotech Hunter | Biotech Hunter